Medpace Holdings, Inc.
MEDP
Rang in aandelen
#1209
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a... Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
Aandeelprijs
$663.11
Marktkapitalisatie
$18.51B
Verandering (1 dag)
0.10%
Verandering (1 jaar)
21.28%
Land
US
Handel Medpace Holdings, Inc. (MEDP)
Categorie
Healthcare
Koersgeschiedenis voor Medpace Holdings, Inc. (MEDP)
Hoogste slotkoers: $618.83 op 2026-10-01
Laagste slotkoers: $28.30 op 2016-08-01
Laagste slotkoers: $28.30 op 2016-08-01
Koersgeschiedenis van Medpace Holdings, Inc. van 2016 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | -4.62% |
| 2025 | 64.84% |
| 2024 | 15.73% |
| 2023 | 41.41% |
| 2022 | -2.02% |
| 2021 | 53.55% |
| 2020 | 71.69% |
| 2019 | 48.38% |
| 2018 | 52.53% |
| 2017 | 0.13% |
| 2016 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $687.28 | 21.17% |
US
|
|
| $233.21 | 6.93% |
US
|
|
| $400.37 | 112.94% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $175.78 | 20.50% |
US
|
